Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes.

Publication

Citation
Storer RI, Pike A, Swain NA, Alexandrou AJ, Bechle BM, Blakemore DC, Brown AD, Castle NA, Corbett MS, Flanagan NJ, Fengas D, Johnson MS, Jones LH, Marron BE, Payne CE, Printzenhoff D, Rawson DJ, Rose CR, Ryckmans T, Sun J, Theile JW, Torella R, Tseng E, Warmus JS.: Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes. Bioorg Med Chem Lett, Volume 27 (21), 2017
Authors
Alexandrou AJ, Bechle BM, Blakemore DC, Brown AD, Castle NA, Corbett MS, Fengas D, Flanagan NJ, Johnson MS, Jones LH, Marron BE, Payne CE, Pike A, Printzenhoff D, Rawson DJ, Rose CR, Ryckmans T, Storer RI, Sun J, Swain NA, Theile JW, Torella R, Tseng E, Warmus JS.
Journal
Bioorg Med Chem Lett
Year
2017
PubMed
29029933
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes. | MolMeDB